Share
Pharmaceutical Contract Manufacturing Market Size, Share, and Analysis, By Molecule Type (Small Molecules, Large Molecules), By Service (Pharmaceutical Manufacturing Services, Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services, Drug Development Services, Biologic Manufacturing Services, Biologic API Manufacturing Services, Biologic FDF Manufacturing Services), By End User (Big Pharmaceutical Companies, Small & Mid-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users [Academic Institutes, Small CDMOs, and CROs]) and Regional Forecasts, 2022-2032.
Pharmaceutical Contract Manufacturing Market size was USD 133.5 billion in 2021 and projected to grow from USD 155.0 billion in 2023 to USD 307.3 billion by 2032, exhibiting a CAGR of 7.9% during the forecast period.
Pharmaceutical Contract Manufacturing is the method by which pharmaceutical medications are made under the contract. In short, drug companies collaborate with a manufacturing business to create a necessary quantity of their service or product and expedite production. A contract development and manufacturing organization (CDMO) manages all operations starting from pre-formulation as well as formulation development to production and clinical trials, as opposed to a contract manufacturing organization (CMO), which makes pre-formulated drugs.
Pharmaceutical Contract Manufacturing market is expected to reach USD 307.3 billion, growing at a CAGR of 7.9% during the forecast period owing to factors like increasing research activities as well as investments in generic medications. Moreover, the significant price of in-house drug development and the regulatory filling support offered by CDMOs are propelling the expansion of the market.
Pharmaceutical Contract Manufacturing Market is classified based on the Service into Pharmaceutical Manufacturing Services, Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services, Drug Development Services, Biologic Manufacturing Services, Biologic API Manufacturing Services, and Biologic FDF Manufacturing Services. The Pharmaceutical Manufacturing Services segment held the majority share of the market in the past years. The expanding pharmaceutical and biopharmaceutical industries worldwide along with the growing need for biologics and biosimilars are some of the contributing factors to the growth.
Pharmaceutical Contract Manufacturing Market is classified based on the End User into Big Pharmaceutical Companies, Small & Mid-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, and Other End Users (Academic Institutes, Small CDMOs, and CROs). Over the forecast period, the Big Pharmaceutical Companies category is anticipated to register the highest CAGR. The market is expected to grow on the back of greater investment in the development of cell & gene therapies, increasing demand for targeted medication therapies, and an increase in the number of biologics now undergoing pipeline investigations.
Increasing Cases of Chronic Disorders worldwide is Expected to Boost the Market Growth
The rising prevalence of chronic diseases among the world's population as well as the steadily growing human population are the key factors affecting the expansion of the pharmaceutical contract manufacturing market in the years to come. The need for improved production capacity in the pharmaceuticals industry is driven by the increase in different types of chronic illnesses including cardiovascular disease, cancer, and infectious diseases. The demand dynamics in the pharmaceutical contract manufacturing market are also boosted by this trend.
Growing Research & Development in Pharmaceutical Manufacturing is Expected to Boost the Market Growth
Growing pharmaceutical manufacturing research and development is significantly influencing market expansion. The rising cost of healthcare as well as various strategic alliances and collaborations among the players in the pharmaceutical and healthcare industries are some other key factors impacting the pharmaceutical contract manufacturing market.
Strict Government Regulatory Orders and their Controls to Restrain the Market Growth
The severe government regulatory frameworks and associated restrictions, as well as ongoing enhancements in the stringent policies and rules imposed by governments of growing nations, impede the expansion of the pharmaceutical contract manufacturing industry. Gene and cell therapies can also address unmet medical needs in the treatment of several illnesses or diseases due to their highly personalized nature. Owing to high therapeutic promise of these medications, numerous investors and pharmaceutical companies have committed significant financial resources to their development and marketing.
(Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Pharmaceutical Contract Manufacturing Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America held the highest market share in 2021, followed by Asia-Pacific and Europe region. The huge market share of North America is the result of a variety of reasons, including the existence of a sizable number of pharmaceutical firms and the rising demand for generic medications. Also, the North American pharmaceutical market is expanding due to expanded research funding for pharmaceutical contract manufacturing and development.
The entry of coronavirus-related vaccines, rising antiviral vaccines, rising antibody therapies, and a variety of pharmaceutical products during the forecast period had a positive effect on the pharmaceutical contract manufacturing market. To preserve their long-term viability, pharmaceutical businesses are encouraged to outsource pharmaceutical production and drug development to contract development and manufacturing businesses.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2032 |
|
Base Year |
2022 |
|
Forecast Period |
2022-2032 |
|
Historical Period |
2019-2021 |
|
Growth Rate |
CAGR of 7.9% from 2022-2032 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
Molecule Type |
|
|
Service |
|
|
End User |
|
|
By Region |
|
Pharmaceutical Contract Manufacturing Market size was estimated at USD 133.5 billion in 2021 and is expected to reach USD 307.3 billion in 2032.
Pharmaceutical Contract Manufacturing is the method by which pharmaceutical medications are made under the contract. In short, drug companies collaborate with a manufacturing business to create a necessary quantity of their service or product and expedite production.
Pharmaceutical Manufacturing Services and Big Pharmaceutical Companies segments accounted for the largest Pharmaceutical Contract Manufacturing market share.
Key players: Thermo Fisher Scientific, CR Pharmaceutical Group, Boehringer Ingelheim Group, AbbVie Contract Manufacturing, WuXi App Tech., Dr. Reddy's Laboratories, Lonza Group, Catalent, Recípharm AB, The Almac Group, Curia Global, Cambrex Corporation, Carlyle Group, Aenova Group GmbH, Pfizer CentreOne, and Other Prominent Players are the key players in the Pharmaceutical Contract Manufacturing Market.
Growth in the global pharmaceutical contract manufacturing market is fuelled by rising pharmaceutical research and development spending, increased generics demand, and contract manufacturing and research services investments in mature manufacturing technologies.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
